异种移植:免疫介导损伤机制的当前认识
本文综述近几十年肾脏异种移植的突破与未克服的免疫障碍。文章指出供器官短缺促使异种移植成为潜在解决方案,基因工程与新型免疫抑制剂改善了非人灵长类临床前研究中异种移植物存活,但适应性及固有免疫介导的损伤仍是挑战。理解细胞与分子层面的排斥机制对靶向基因改造和诱导耐受至关重要。
要点
- 异种移植可望解决供器官短缺,但跨物种免疫不相容是核心障碍。
- 基因工程与新型免疫抑制剂已改善非人灵长类临床前异种移植物存活。
- 适应性与固有免疫介导的异种移植物损伤机制尚待阐明以开发靶向策略。
核心结论
- 异种移植在临床前研究中取得进展,但适应性与固有免疫介导的异种移植物损伤仍是尚未克服的免疫学障碍。
研究设计与样本
- 本文为综述,回顾近几十年肾脏异种移植的突破并聚焦尚未克服的免疫学障碍。
主要发现
- 基因工程与新型免疫抑制剂的进展使非人灵长类临床前研究中异种移植物存活获得显著改善。
- 近期有报道在同情用药基础上将基因修饰猪肾和心脏移植给人类 deceased 及活体受者。
- 迄今在非人灵长类与人类中的研究描述了适应性及固有免疫介导的异种移植物损伤。
临床怎么用
- 需在细胞与分子层面理解异种移植物排斥机制,以指导靶向基因修饰与创新治疗策略。
- 还需理解并调控人类宿主与猪异种移植物之间双向通讯的生理学组分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The scarcity of transplantable organs represents a worldwide public health crisis, and as a result, thousands of people with kidney failure die waiting for a transplant each year. Xenotransplantation involves transplanting organs from an animal source into humans, offering a potential solution to this significant unmet need. Indeed, if there is a limitless supply of organs, many more patients who do not meet the current criteria for transplant eligibility could also be considered as candidates. Although there are examples of attempts to transplant animal tissues or organs into humans dating back over 300 years, none were successful due to cross-species immunologic incompatibility. Even so, significant advances in genetic engineering and the emergence of novel immunosuppressive agents have spurred impressive improvements in xenograft survival in preclinical studies involving nonhuman primates. Furthermore, recent reports of genetically modified pig kidney and heart xenotransplants in human decedents and living recipients on a compassionate use basis have provided impetus to advancing the field toward first-in-human trials. However, studies in nonhuman primates and humans thus far have described adaptive as well as innate immune-mediated xenograft injury. Understanding the mechanistic aspects of these responses at the cellular and molecular levels is critical to the development of targeted genetic modifications and innovative therapeutic strategies aimed at preventing rejection and inducing tolerance. Moreover, the physiologic components of the bidirectional communication between the human host and pig xenograft must also be understood and manipulated. Here, we review the breakthroughs in kidney xenotransplantation in the past few decades and highlight the immunologic hurdles that have yet to be overcome.
引用
- Tatapudi VS, Mattoo A, Schiff T, et al. Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated Injury. J Am Soc Nephrol. 2025. PMID: 40238253. doi:10.1681/ASN.0000000745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。